In our current project, we built on previous hypotheses and asked whether a combined action to increase PU.1 levels can establish a leukemic differentiation effect that would be of a more sustainable character, thereby enhancing the redirection of AML cells while suppressing the leukemic phenotype. The gene discussed is SPI1; the disease is acute myeloid leukemia.